Skip to main content
Top
Published in: Journal of Clinical Immunology 4/2007

01-07-2007

Clinical Follow-Up of 11 Argentinian CD40L-Deficient Patients with 7 Unique Mutations Including the So-Called “Milder” Mutants

Authors: SILVIA DANIELIAN, MATIAS OLEASTRO, MARIA EVA RIVAS, CLAUDIO CANTISANO, MARTA ZELAZKO

Published in: Journal of Clinical Immunology | Issue 4/2007

Login to get access

Abstract

CD40 ligand (CD40L) deficiency is an X-linked combined immunodeficiency characterized by impaired class switch recombination. We analyzed clinical and molecular findings in 11 Argentinian patients from seven unrelated families. The mean age at onset of symptoms was 1.1 years (0.5–3.0 years) and the 10 alive patients have a median age of 17 years. We identified two nonsense mutations, including R11X reported as a “hypomorphic” defect, four missense mutations, and one point deletion. Although R11X was associated herein with parvovirus B19-anemia and higher Igs levels as previously described, histoplasmosis and Pneumocystis jiroveci pneumonia were also present. Other so-called “milder” mutation, T254M, was present in three related patients clinically and immunologically undistinguishable from the rest of the cohort. Furthermore, 10 of the 11 patients, having heterogeneous mutations, never had persistent neutropenia, none presented Cryptosporidium sp. infection nor developed liver-biliary tract disease, highlighting the debatable concept of “milder” mutations.
Literature
1.
go back to reference Korthauer U, Graf D, Mages HW, Briere F, Padayachee M, Malcolm S, Ugazio AG, Notarangelo LD, Levinsky RJ, Kroczek RA: Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 361:539–541, 1993PubMedCrossRef Korthauer U, Graf D, Mages HW, Briere F, Padayachee M, Malcolm S, Ugazio AG, Notarangelo LD, Levinsky RJ, Kroczek RA: Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 361:539–541, 1993PubMedCrossRef
2.
go back to reference Di Santo JP, Bonnefoy JY, Gauchat JF, Fischer A, de Saint Basile G: CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature 361:541–543, 1993CrossRef Di Santo JP, Bonnefoy JY, Gauchat JF, Fischer A, de Saint Basile G: CD40 ligand mutations in X-linked immunodeficiency with hyper-IgM. Nature 361:541–543, 1993CrossRef
3.
go back to reference Aruffo A, Farrington M, Hollenbaugh D, Li X, Milatovich A, Nonoyama S, Bajorath J, Grosmaire LS, Stenkamp R, Neubauer M, Roberts RL, Noelle RJ, Ledbetter JA, Francke U, Ochs HD: The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM Syndrome. Cell 72:291–300, 1993PubMedCrossRef Aruffo A, Farrington M, Hollenbaugh D, Li X, Milatovich A, Nonoyama S, Bajorath J, Grosmaire LS, Stenkamp R, Neubauer M, Roberts RL, Noelle RJ, Ledbetter JA, Francke U, Ochs HD: The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM Syndrome. Cell 72:291–300, 1993PubMedCrossRef
4.
go back to reference Allen RC, Armitage RJ, Conley ME, Rosenblatt H, Jenkins NA, Copeland NG, Bedell MA, Edelhoff S, Disteche CM, Simoneaux DK, Fanslow WC, Belmont JW, Spriggs MK: CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 259:990–993, 1993PubMedCrossRef Allen RC, Armitage RJ, Conley ME, Rosenblatt H, Jenkins NA, Copeland NG, Bedell MA, Edelhoff S, Disteche CM, Simoneaux DK, Fanslow WC, Belmont JW, Spriggs MK: CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 259:990–993, 1993PubMedCrossRef
5.
go back to reference Ferrari S, Giliani S, Insalaco A, Al-Ghonaium A, Soresina AR, Loubser M, Avanzini MA, Marconi M, Badolato R, Ugazio AG, Levy Y, Catalan N, Durandy A, Tbakhi A, Notarangelo LD, Plebani A: Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. Proc Natl Acad Sci USA 98:12614–12619, 2001PubMedCrossRef Ferrari S, Giliani S, Insalaco A, Al-Ghonaium A, Soresina AR, Loubser M, Avanzini MA, Marconi M, Badolato R, Ugazio AG, Levy Y, Catalan N, Durandy A, Tbakhi A, Notarangelo LD, Plebani A: Mutations of CD40 gene cause an autosomal recessive form of immunodeficiency with hyper IgM. Proc Natl Acad Sci USA 98:12614–12619, 2001PubMedCrossRef
6.
go back to reference Notarangelo LD, Lanzi G, Peron S, Durandy A: Defects of class-switch recombination. J Allergy Clin Immunol 117:855–864, 2006PubMedCrossRef Notarangelo LD, Lanzi G, Peron S, Durandy A: Defects of class-switch recombination. J Allergy Clin Immunol 117:855–864, 2006PubMedCrossRef
7.
go back to reference Conley ME, Notarangelo LD, Etzioni A: Diagnostic criteria for primary immunodeficiencies. Clin Immunol 93:190–197, 1999PubMedCrossRef Conley ME, Notarangelo LD, Etzioni A: Diagnostic criteria for primary immunodeficiencies. Clin Immunol 93:190–197, 1999PubMedCrossRef
8.
go back to reference Villa A, Notarangelo LD, Di Santo JP, Macchi PP, Strina D, Frattini A, Lucchini F, Patrosso CM, Giliani S, Mantuano E, Agosti S, Nocera G, Kroczek RA, Fischer A, Ugazio AG, de Saint Basile G, Vezzoni P: Organization of the human CD40L gene: Implications for molecular defects in X chromosome-linked hyper-IgM syndrome and prenatal diagnosis. Proc Natl Acad Sci USA 91:2110–2114, 1994PubMedCrossRef Villa A, Notarangelo LD, Di Santo JP, Macchi PP, Strina D, Frattini A, Lucchini F, Patrosso CM, Giliani S, Mantuano E, Agosti S, Nocera G, Kroczek RA, Fischer A, Ugazio AG, de Saint Basile G, Vezzoni P: Organization of the human CD40L gene: Implications for molecular defects in X chromosome-linked hyper-IgM syndrome and prenatal diagnosis. Proc Natl Acad Sci USA 91:2110–2114, 1994PubMedCrossRef
9.
go back to reference Seyama K, Nonoyama S, Gangsaas I, Hollenbaugh D, Pabst HF, Aruffo A, Ochs HD: Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome. Blood 92:2421–2434, 1998PubMed Seyama K, Nonoyama S, Gangsaas I, Hollenbaugh D, Pabst HF, Aruffo A, Ochs HD: Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome. Blood 92:2421–2434, 1998PubMed
10.
go back to reference Blaeser F, Kelly M, Siegrist K, Storch GA, Buller RS, Whitlock J, Truong N, Chatila TA: Critical function of the CD40 pathway in parvovirus B19 infection revealed by a hypomorphic CD40 ligand mutation. Clin Immunol 117:231–237, 2005PubMedCrossRef Blaeser F, Kelly M, Siegrist K, Storch GA, Buller RS, Whitlock J, Truong N, Chatila TA: Critical function of the CD40 pathway in parvovirus B19 infection revealed by a hypomorphic CD40 ligand mutation. Clin Immunol 117:231–237, 2005PubMedCrossRef
11.
go back to reference Lin Q, Rohrer J, Allen RC, Larché M, Greene JM, Shigeoka AO, Gatti RA, Derauf DC, Belmont JW, Conley ME: A single strand conformation polymorphism study of CD40 ligand. J Clin Invest 97:196–201, 1996PubMedCrossRef Lin Q, Rohrer J, Allen RC, Larché M, Greene JM, Shigeoka AO, Gatti RA, Derauf DC, Belmont JW, Conley ME: A single strand conformation polymorphism study of CD40 ligand. J Clin Invest 97:196–201, 1996PubMedCrossRef
12.
go back to reference Katz F, Hinshelwood S, Rutland P, Jones A, Kinnon C, Morgan G: Mutation analysis in CD40 ligand deficiency leading to X-linked hypogammaglobulinemia with hyper IgM syndrome. Hum Mutat 8:223–228, 1996PubMedCrossRef Katz F, Hinshelwood S, Rutland P, Jones A, Kinnon C, Morgan G: Mutation analysis in CD40 ligand deficiency leading to X-linked hypogammaglobulinemia with hyper IgM syndrome. Hum Mutat 8:223–228, 1996PubMedCrossRef
13.
go back to reference Nonoyama S, Shimadzu M, Toru H, Seyama K, Nunoi H, Neubauer M, Yata J, Ochs HD: Mutations of the CD40 ligand gene in 13 Japanese patients with X-linked hyper-IgM syndrome. Hum Genet 99:624–627, 1997PubMedCrossRef Nonoyama S, Shimadzu M, Toru H, Seyama K, Nunoi H, Neubauer M, Yata J, Ochs HD: Mutations of the CD40 ligand gene in 13 Japanese patients with X-linked hyper-IgM syndrome. Hum Genet 99:624–627, 1997PubMedCrossRef
14.
go back to reference Garber E, Su L, Ehrenfels B, Karpusas M, Hsu Y-M: CD154 variants associated with hyper-IgM syndrome can form oligomers and trigger CD40-mediated signals. J Biol Chem 274:33545–33550, 1999PubMedCrossRef Garber E, Su L, Ehrenfels B, Karpusas M, Hsu Y-M: CD154 variants associated with hyper-IgM syndrome can form oligomers and trigger CD40-mediated signals. J Biol Chem 274:33545–33550, 1999PubMedCrossRef
15.
go back to reference Ziegner UHM, Kobayashi RH, Cunningham-Rundles C, Español T, Fasth A, Huttenlocker A, Krogstad P, Marthinsen L, Notarangelo LD, Pasic S, Rieger CHL, Rudge P, Sankar R, Shigeoka AO, Stiehm ER, Sullivan KE, Webster AD, Ochs HD: Progressive neurodegeneration in patients with primary immunodeficiency disease on IVIG treatment. Clin Immunol 102:19–24, 2002PubMedCrossRef Ziegner UHM, Kobayashi RH, Cunningham-Rundles C, Español T, Fasth A, Huttenlocker A, Krogstad P, Marthinsen L, Notarangelo LD, Pasic S, Rieger CHL, Rudge P, Sankar R, Shigeoka AO, Stiehm ER, Sullivan KE, Webster AD, Ochs HD: Progressive neurodegeneration in patients with primary immunodeficiency disease on IVIG treatment. Clin Immunol 102:19–24, 2002PubMedCrossRef
16.
go back to reference Levy J, Español-Boren T, Thomas C, Fischer A, Tobo P, Bordigoni P, Resnick I, Fasth A, Baer M, Gómez L, Sandera EA, Tabone M-D, Plantaz D, Etzioni A, Monafo V, Abinum M, Hammarstrom L, Abrahamsen T, Jones A, Finn A, Klemola T, DeVries E, Sanal O, Peitsch MC, Notarangelo LD: Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr 131:47–54, 1997PubMedCrossRef Levy J, Español-Boren T, Thomas C, Fischer A, Tobo P, Bordigoni P, Resnick I, Fasth A, Baer M, Gómez L, Sandera EA, Tabone M-D, Plantaz D, Etzioni A, Monafo V, Abinum M, Hammarstrom L, Abrahamsen T, Jones A, Finn A, Klemola T, DeVries E, Sanal O, Peitsch MC, Notarangelo LD: Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr 131:47–54, 1997PubMedCrossRef
17.
go back to reference Winkelstein JA, Marino MC, Ochs HD, Fuleihan R, Scholl PR, Geha R, Stiehm ER, Conley ME: The X-linked hyper-IgM syndrome. Medicine 82:373–384, 2003PubMedCrossRef Winkelstein JA, Marino MC, Ochs HD, Fuleihan R, Scholl PR, Geha R, Stiehm ER, Conley ME: The X-linked hyper-IgM syndrome. Medicine 82:373–384, 2003PubMedCrossRef
18.
go back to reference Lee W-I, Torgerson TR, Schumacher MJ, Yel L, Zhu Q, Ochs HD: Molecular analysis of a large cohort of patients with the hyper IgM syndrome (HIGM). Blood 105:1881–1890, 2005PubMedCrossRef Lee W-I, Torgerson TR, Schumacher MJ, Yel L, Zhu Q, Ochs HD: Molecular analysis of a large cohort of patients with the hyper IgM syndrome (HIGM). Blood 105:1881–1890, 2005PubMedCrossRef
19.
go back to reference de Vries E, Noordzij JG, Davies EG, Hartwig N, Breuning MH, Van Dongen JJM, Van Tol MJD: The 782C->T (T254M) XHIM mutation: Lack of a tight phenotype–genotype relationship. Blood 94:1488–1490, 1999PubMed de Vries E, Noordzij JG, Davies EG, Hartwig N, Breuning MH, Van Dongen JJM, Van Tol MJD: The 782C->T (T254M) XHIM mutation: Lack of a tight phenotype–genotype relationship. Blood 94:1488–1490, 1999PubMed
20.
go back to reference Litinskiy MB, Nardelli B, Hilbert DM, He B, Schaffer A, Casali P, Cerutti A: DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol 3:822–829, 2002PubMedCrossRef Litinskiy MB, Nardelli B, Hilbert DM, He B, Schaffer A, Casali P, Cerutti A: DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol 3:822–829, 2002PubMedCrossRef
21.
go back to reference den Dunnen JT, Antonarakis SE: Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion. Hum Mutat 15:7–12, 2000PubMedCrossRef den Dunnen JT, Antonarakis SE: Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion. Hum Mutat 15:7–12, 2000PubMedCrossRef
Metadata
Title
Clinical Follow-Up of 11 Argentinian CD40L-Deficient Patients with 7 Unique Mutations Including the So-Called “Milder” Mutants
Authors
SILVIA DANIELIAN
MATIAS OLEASTRO
MARIA EVA RIVAS
CLAUDIO CANTISANO
MARTA ZELAZKO
Publication date
01-07-2007
Published in
Journal of Clinical Immunology / Issue 4/2007
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-007-9089-8

Other articles of this Issue 4/2007

Journal of Clinical Immunology 4/2007 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.